Castaneda CA - Search Results

1

Human Papillomavirus, Cytomegalovirus Infection and P16 Staining in Breast Tumors from Peruvian Women.

Calderon G, Castaneda CA, Castillo M, Sanchez J, Bernabe L, Suarez N, Tello K, Torres E, Cotrina JM, Dunstan J, De-La-Cruz M, Abugattas J, Guerra H, Manrique JE, Aguayo F, Gomez HL. Calderon G, et al. Among authors: castaneda ca. Asian Pac J Cancer Prev. 2022 May 1;23(5):1571-1576. doi: 10.31557/APJCP.2022.23.5.1571. Asian Pac J Cancer Prev. 2022. PMID: 35633540 Free PMC article.

2

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer.

Castañeda CA, Gomez HL. Castañeda CA, et al. Nat Rev Clin Oncol. 2009 Jun;6(6):308-9. doi: 10.1038/nrclinonc.2009.68. Nat Rev Clin Oncol. 2009. PMID: 19483734

3

Pazopanib: an antiangiogenic drug in perspective.

Castaneda CA, Gomez HL. Castaneda CA, et al. Future Oncol. 2009 Nov;5(9):1335-48. doi: 10.2217/fon.09.112. Future Oncol. 2009. PMID: 19903063 Review.

4

Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.

Castaneda CA, Gómez HL. Castaneda CA, et al. Clin Breast Cancer. 2009 Nov;9(4):E1-3. doi: 10.3816/CBC.2009.n.046. Clin Breast Cancer. 2009. PMID: 19933071

5

Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients.

Gómez HL, Castañeda CA, Vigil CE, Vidaurre T, Velarde RG, Cruz WR, Pinto JA, Suazo JF, Garcés MR, Neciosup SP, Vallejos CS. Gómez HL, et al. Among authors: castaneda ca. Hematol Oncol Stem Cell Ther. 2010;3(3):109-15. doi: 10.1016/s1658-3876(10)50020-7. Hematol Oncol Stem Cell Ther. 2010. PMID: 20890067 Free article.

6

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer.

Castaneda CA, Cortes-Funes H, Gomez HL, Ciruelos EM. Castaneda CA, et al. Cancer Metastasis Rev. 2010 Dec;29(4):751-9. doi: 10.1007/s10555-010-9261-0. Cancer Metastasis Rev. 2010. PMID: 20922461 Review.

7

Implication of miRNA in the diagnosis and treatment of breast cancer.

Castañeda CA, Agullo-Ortuño MT, Fresno Vara JA, Cortes-Funes H, Gomez HL, Ciruelos E. Castañeda CA, et al. Expert Rev Anticancer Ther. 2011 Aug;11(8):1265-75. doi: 10.1586/era.11.40. Expert Rev Anticancer Ther. 2011. PMID: 21916580 Review.

8

Behaviour of breast cancer molecular subtypes through tumour progression.

Castaneda CA, Andrés E, Barcena C, Gómez HL, Cortés-Funés H, Ciruelos E. Castaneda CA, et al. Clin Transl Oncol. 2012 Jun;14(6):481-5. doi: 10.1007/s12094-012-0827-x. Clin Transl Oncol. 2012. PMID: 22634538

9

Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma.

Castaneda CA, Flores R, Rojas K, Flores C, Castillo M, Milla E. Castaneda CA, et al. Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):149-56. doi: 10.1016/j.hemonc.2014.09.001. Epub 2014 Oct 6. Hematol Oncol Stem Cell Ther. 2014. PMID: 25300565 Free article.

10

PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.

Castaneda CA, Lopez-Ilasaca M, Pinto JA, Chirinos-Arias M, Doimi F, Neciosup SP, Rojas KI, Vidaurre T, Balko JM, Arteaga CL, Gomez HL. Castaneda CA, et al. Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):142-8. doi: 10.1016/j.hemonc.2014.09.007. Epub 2014 Oct 29. Hematol Oncol Stem Cell Ther. 2014. PMID: 25467032 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters